YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Amgen to buy Horizon Therapeutics for $26B

Posted online

Amgen entered a deal to purchase drugmaker Horizon Therapeutics.

The acquisition is valued at more than $26 billion.

Amgen, which makes biotech drugs, would get a treatment for thyroid eye disease through the Horizon deal.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Court Connection: New pickleball paddle retailer connects with OMB Bank on partnership

An Ozark resident is aiming to serve up retail sales with a focus on the rapidly growing sport of pickleball.

Most Read
SBJ.net Poll
Update cookies preferences